ADVFN - Advanced Financial Network.
HOME» NYSE » B » BCR Stock Price » BCR Stock News

Bard C R Share News

 Bard (c.r.), Inc. Stock Price
BCR Stock Price
 Bard (c.r.), Inc. Stock Chart
BCR Stock Chart
 Bard (c.r.), Inc. Stock News
BCR Stock News
 Bard (c.r.), Inc. Company Information
BCR Company Information
 Bard (c.r.), Inc. Stock Trades
BCR Stock Trades

C.R. Bard 1Q Profit Rises 8.8% On Vascular Sales

DOW JONES NEWSWIRES Medical-device maker C.R. Bard Inc.'s (BCR) first-quarter profit rose a better-than-expected 8.8% on revenue growth in its main vascular business. A rebound in spending in the health-care sector has driven renewed profits at companies like C.R. Bard, which has posted solid revenue growth on strong performance in the vascular business, its largest by revenue. The company has also worked to control costs. "Through the strength of our diversified portfolio, we delivered strong revenue and earnings growth again this quarter, despite the fact that we saw no measurable improvement in hospital volumes and procedures," Chairman and Chief Executive Timothy M. Ring said. C.R. Bard posted a first-quarter profit of $131.9 million, or 1.49 cents a share, up from $120.9 million, or $1.24 a share, a year earlier. Excluding acquisition-related charges, prior-year restructuring costs and other items, earnings rose to $1.51 from $1.25 a share. Revenue rose 7.6% to $700.3 million on both a reported and a constant-currency basis. The company in January projected a per-share profit of $1.43 to $1.47 on 6% to 8% revenue growth. Gross margin rose to 62.2% from 61.2%. Sales in the urology segment edged up 3%, while vascular business revenue jumped 15%. Oncology and surgical specialties revenues grew 7.1% and 5.2%, respectively. Shares rose 1.3% to $104.46 after-hours. The stock has climbed 20% over the past year through the close. -By Drew FitzGerald, Dow Jones Newswires; 212-416-2909; Andrew.FitzGerald@dowjones.com

Stock News for Bard C R (BCR)
DateTimeHeadline
06/13/201408:51:38U.S. Hot Stocks: Hot Stocks to Watch
11/15/201308:47:28ValueAct Capital Management LP 3Q 13F: Holdings As Of Sep 30
11/15/201308:18:57Farallon Capital Management 3Q 13F: Largest Eliminations
11/15/201308:18:52Farallon Capital Management 3Q 13F: Holdings As Of Sep 30
11/15/201307:07:30Two Sigma Investments 3Q 13F: Largest Eliminations
11/15/201307:07:27Two Sigma Investments 3Q 13F: Largest Eliminations -2-
11/15/201307:07:27Two Sigma Investments 3Q 13F: Largest Purchases
11/15/201307:07:27Two Sigma Investments 3Q 13F: Largest Sales
11/15/201307:04:50Bridgewater Associates LP 3Q 13F: Largest Purchases
11/15/201307:04:50Bridgewater Associates LP 3Q 13F: Holdings As Of -2-
11/15/201307:04:50Bridgewater Associates LP 3Q 13F: Largest -2-
11/15/201307:04:49Bridgewater Associates LP 3Q 13F: Holdings As Of Sep 30
09/04/201309:35:09U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
06/28/201310:54:22Boston Scientific to Buy C.R. Bard Unit for $275 Million
10/25/201218:32:16High-Grade-Bond Market Absorbs $3.9 Billion of New Deals
06/05/201212:53:24J&J to Stop Selling Surgical Mesh Amid Lawsuits, Concerns -AP
04/21/201200:20:37MARKET SNAPSHOT: U.S. Stock Gains Hinge On Apple, Blue-chip Results
01/04/201216:13:14FDA Orders Post-Market Testing Of Surgical Mesh Amid Safety Concerns
12/21/201109:10:36US Stock Futures: HOT STOCKS TO WATCH
10/26/201107:57:35US Stock Futures Higher On Optimism Ahead Of EU Summit

Bard C R and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad